Holen Sie sich die Stockscreener-App
1.59
1.85%
-0.03
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.75%
0.9669
|
1.0259 | 1.0242 | 1.67 | 1.3701 |
| Interest Income/Expense |
29.17%
0.00719
|
0.0101 | 0.000279 | 0.00195 | 0.00386 |
| Operating Income/Loss |
5.75%
-0.9669
|
-1.0259 | -1.0242 | -1.67 | -1.3701 |
| Income/Loss From Continuing Operations Before Tax |
5.90%
-0.9713
|
-1.0323 | -1.0188 | -1.6684 | -1.3677 |
| Income/Loss From Continuing Operations After Tax |
5.90%
-0.9713
|
-1.0323 | -1.0188 | -1.6684 | -1.3677 |
|
Net Income/Loss
|
5.90%
-0.9713
|
-1.0323 | -1.0188 | -1.6684 | -1.3677 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,902%
2.2493
|
0.1124 | 2.0749 | 1.666 | 16.65 |
| Diluted Average Shares |
1,902%
2.2493
|
0.1124 | 2.0749 | 1.666 | -0.000477 |
| Basic Earnings Per Share |
4.88%
-0.43
|
-0.41 | -0.49 | -1.00 | -0.08 |
| Diluted Earnings Per Share |
4.88%
-0.43
|
-0.41 | -0.49 | -1.00 | -0.82 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):